Access
Access to insulin
Insulin is not optional treatment for Type 1 Diabetes — it is life support. Access should not depend on where a family lives.
Insulin every single day
People with T1D produce no insulin at all. Missing doses for even a day can lead to DKA, so supply cannot be interrupted.
Urban and rural gaps
Pharmacies in large cities usually stock modern analogue insulin. District and island pharmacies may stock little or nothing, forcing long repeat journeys.
Healthcare and insurance barriers
Coverage exists, but referral letters, quotas, renewal paperwork and out-of-pocket gaps for strips and needles still create real cost.
Refrigeration and storage
Insulin degrades in heat. Unstable electricity or no refrigerator at home makes safe storage difficult in a tropical climate.
Monitoring technology
Continuous glucose monitors and insulin pumps improve outcomes dramatically but are largely self-funded and out of reach for most families.
Distance to a stocked pharmacy
Families report travelling several hours each month, adding transport cost to the price of staying alive.
Regional picture
Placeholder regional view. As survey responses arrive, each region will show reported insulin availability, travel distance and cost burden.
Sumatera
Awaiting data
Jawa
Awaiting data
Kalimantan
Awaiting data
Sulawesi
Awaiting data
Bali & Nusa Tenggara
Awaiting data
Maluku & Papua
Awaiting data